Tonix Pharmaceuticals Holding Corp (TNXP)

[Value_Investor]

Based on all the past year's hard facts! The Crap CEO here has been Consistently Scamming TNXP investors for many many years through the Endless Super Heavy Dilutions then a Big R/S Death-Spiral circle! He should be put in the jail forever to show the justice to all the investors here if the SEC and FBI really care about the TNXP investors! Unfortunately he could always escape any severe punishment or long-term sentence based on the Corrupt system!

Anyway TNXP will crash further to $1.4857 based on the Same percentage of Bottom price crashing record of its NASDAQ peer (TBLT: from $21 to $6.5 so far)! Sell ASAP before it is too late...

Hopefully after it hits the Final Bottom $1.4857 TNXP could bounce the Same 5.2-Bagger like its peer (PBHG) did most recently --- from previous Bottom 0.0005 to 12/30/2021-high 0.0026!

[HoanTuong]

What do you know? Not nice to critisize a CEO !!

[Value_Investor]

The Crap CEO here has been Consistently Scamming TNXP investors for many years through the Endless Super Heavy Dilutions then a Big R/S Death-Spiral circle! He should be put in the jail forever to show the justice to all the investors here if the SEC and FBI really care about the TNXP investors! Unfortunately he could always escape any severe punishment or long-term sentence based on the Corrupt system!

Anyway TNXP will crash further to $1.5542 based on the Same percentage of Bottom price crashing record of its NASDAQ peer (TBLT: from $21 to $6.8 so far)! Sell ASAP before it is too late...

[Value_Investor]

New 52-week-low $1.91 was created yesterday! TNXP is heading onto its Final Bottom $1.6388 now... Sell this Super-Heavy Endless Diluting Pos Scam ASAP before it is too late! Buy its Marijuana & Cannabis FIXED-SS peer (PBHG) at currently the Cheapest price levels 0.000x ASAP to recover the Huge losses here since PBHG did Easily And Quickly soar 55-Bagger or 5400% recently!

[hogg]

Divide price by 32

[Awl416]

So what’s pre spilt level here given the PM pop

[stockmavin]

Hey the poor man needs to pay his grand a month hoa on his million dollar plus condo on E96 st( public record)

The warnings were like seeing the Hindenburg on fire heading to the ground and saying, “it’s going to crash”, as if that wasn’t obvious.

[Value_Investor]

I ever warned everyone here long time ago --- On-Going Endless Super Heavy diluting TNXP is the Biggest Repeated Big R/S Pos Scam! The current New low $2.16 is Far beyond its Final Bottom since it will crash further to $1.6388 based on the Same performance of its NASDAQ peer (TBLT)!

Sell ASAP before it is too late because A Series Of New 52-Week Lows will be created till $1.6388...

Note, TNXP has 18,739,988 (not 15,507,674) shares of Diluting OS now after the 1:32 Big R/S today v.s. TBLT has the FIXED 861,911 shares of Super Tiny OS! The previous OS was only 13,737,196 shares on 11/05/2021.

I'll liquidate all my remaining FREE shares then use all the cash proceeds to buy a Marijuana and Cannabis peer (PBHG) to make Huge investment return!

[stockmavin]

What did they say, the R/S will attract investors? Lolol

[Pennyes]

that's it: IT IS OVER FOR TNXP!!...
==========================
."a reverse isn't so bad"!.........Oh yes, bad, no no it is horrible, it is pretty pathetic Ponzhi scheme design!.
R/S........ without any doubt is one of the DIRTIEST, SCAM invention as part of a Ponzhi schemes!...
=================================
Most of the companies employed "RS" never recovered back to normal, stock price performance became worst than pre R/S and stayed that way until another...and never ending R/S!?..
they do not need to be with NASDAG sh..tty place, doing R/S to just satisfy that platform, will end TNXPs future for ever!?.

Remember, it's "no way we are reverse splitting here".... until it happens when it then becomes...."a reverse isn't so bad"!

[pumper_stumper]

1:32! Congrats on the 5th reverse split in TNXP history here!

The great news is the stock price will be much higher tomorrow! Many bullish investors targets will be hit! lol Likely we will be over $2 tomorrow, from 0.0914 right now!

One good reverse deserves another... and another... and another... and that was so good, we get another!

Remember, it's "no way we are reverse splitting here".... until it happens when it then becomes...."a reverse isn't so bad"!

https://www.otcmarkets.com/filing/html?id=15820090&guid=UiKwkn5GrJpVdth

"The Company anticipates that the Reverse Stock Split will be effective at 12:01 a.m., Eastern Time, on May 17, 2022"

[Value_Investor]

TNXP will crash from previous Bottom $0.15 to a New Bottom $0.06 now in order to match the Same performance as its NASDAQ Debt-FREE peer (TBLT) did --- crashed from previous Bottom $21 to the New Bottom $8.4!

[Value_Investor]

TNXP is heading onto a New Bottom $0.06089 now in order to match the Same performance as its peer (TBLT) did --- crashed from $21 to $8.525!

$0.11 will be hit as soon as this afternoon...

[Ruben3009]

Tonix Pharmaceuticals is working on many products, nothing has hit the pipeline yet.
See below: these products are years away.


TNX-102 SL Fibromyalgia (FM)
Mid-Phase III — RESILIENT study enrolling
Mid-Phase III

TNX-102 SL Posttraumatic Stress Disorder (PTSD)
Phase II start — targeting 2Q 2022
Phase II

TNX-102 SL Long COVID
Phase II start — targeting 2Q 2022
Phase II

TNX-601 CR Depression, PTSD, Neurocognitive Dysfunction from Corticosteroids*
Phase II start — targeting 1Q 2023
Phase I

TNX-1300 Cocaine Intoxication / Overdose
Phase II start — targeting 2Q 2022
Phase II

TNX-1900 Chronic Migraine
Phase II start — targeting 2H 2022
Phase II
* Pending IND Clearance


Immunology Portfolio

TNX-1500 Organ Transplant Rejection / Autoimmune Disorders
Phase I start — targeting 2H 2022
Preclinical

TNX-1700 Gastric and Colorectal Cancers
Preclinical


Infectious Disease Portfolio

TNX-102 SL Long COVID
Phase II start — targeting 2Q 2022
Phase II

TNX-1840/TNX-1850 COVID-19 Vaccine
Preclinical

TNX-3500 COVID-19 Small Molecule Antiviral
Preclinical

TNX-801 Smallpox and Monkeypox Preventing Vaccine
Preclinical


Rare Disease Portfolio

TNX-2900 Prader-Willi Syndrome
FDA Orphan Drug Designation
Preclinical

[Value_Investor]

TNXP will crash to $0.07 based on the Same percentage of price crash from previous Bottom $0.15 since its NASDAQ peer (TBLT) did crash to $9.801 from $21 after most recent 100% Quick bounce to $42!

Anyway I wish to see $0.36 again before upcoming inevitable Huge R/S in order to liquidate all my remaining shares here based on On-Going Endless Super Heavy dilutions!

[Value_Investor]

New 52-week-low $0.1399 so far! The On-Going Endless Super Heavy dilutions will soon crash TNXP to A Series Of New 52-Week Lows till $0.07 since its peer (TBLT) has already crashed down over 53.33% to a New low $9.801 from previous Bottom $21!

Note, the Diluting OS was 594,679,596 shares on 05/02/2022 from 439,590,272 shares on 11/05/2021 v.s. TBLT has the FIXED 861,911 shares of Super Tiny OS count!

[Value_Investor]

TNXP will crash to $0.0971 from current Bottom $0.15 based on the NASDAQ-peer's performance --- TBLT just crashed to $13.60 from previous Bottom $21.00 with Much-Much-Much-Lower OS and Much-Much-Much-Higher Book Value and Cash Value!

The OS has already been diluted to 589,679,596 shares as of yesterday (04/25/2022) from 439,590,272 shares on 11/05/2021! What an Huge Diluting Pos Scam here!!!

Anyway I wish "No Huge-R/S" like TBLT did yesterday (1:150 R/S)!

I'll sell all my shares at $0.233 once it bottoms out at $0.0971!

[Value_Investor]

No. I bet A Series Of New 52-Week Lows below current Bottom $0.15 will be created very soon based on its NASDAQ peer's crashing pattern --- TBLT just crashed to $13.69 so far from previous Bottom $21.00 after it just bounced Up 100% to $42.00 last week! So the final New Bottom of TNXP should be $0.0977857 or below!

Anyway I still own large amount of FREE shares now after the most recent TWICE strong bounces. I wish TNXP to hit the Top Ceiling price $0.36 again in the near future!

[IRON_CROSS]

Max pain inflicted- .1540 bottom in; time for reversal.

In for the ascent to $1+

$TNXP - Let's go!

[Value_Investor]

So far I only sold partial my Big position (millions shares) in case it bounces back to $0.36 again. I had already made enough huge gain by selling portion of my holding. I'll add the new positions from the most recent low $0.1734 to the Bottom $0.15 and all the way down to $0.08 or below...

Anyway the Huge-Endless-Super-Heavy-Diluting Latest OS was 562,035,216 shares now as of 04/04/2022 alone v.s. the Previous OS was only 357,521,582 shares on 08/09/2021!

[AndrewDiceClay]

Why?

[Babubd]

Tonix Pharmaceuticals Initiates Enrollment in the RESILIENT Study, a Potentially Pivotal Phase 3 Study of TNX-102 SL for the Management of Fibromyalgia

Results from Planned Interim Analysis Expected First Quarter 2023

A Positive Outcome in RESILIENT Together with Results from Previous Positive Phase 3 Study RELIEF May Support Submission of an NDA

https://ca.finance.yahoo.com/news/tonix-pharmaceuticals-initiates-enrollment-resilient-110000355.html

[Babubd]

Dollar Land is Imminent!! TNXP could be the next OCGN!!! Period.

[Babubd]

Buddy, are you dumping or accumulating??

[Value_Investor]

TNXP (550M shares OS) is heading down to $0.15 now! A Series Of New 52-week lows will be created in the coming days/weeks due to on-going Endless Super Heavy dilutions every day...

Sell this Giant-Diluting Pos Scam ASAP before it breaks down $0.1734!

Buy the FIXED Super Tiny OS (mere 28M shares over a year without any single share dilution at all) NASDAQ Bio-Tech peer (VYNT) to cover the Huge Losses here!

[Babubd]

Tonix Pharmaceuticals Announces IND Clearance for TNX-102 SL as a Potential Treatment for Long COVID Syndrome, Also Known as Post-Acute Sequelae of COVID-19 (PASC)

Phase 2 Clinical Trial of TNX-102 SL for the Treatment of Long COVID Expected to Start Second Quarter 2022

Long COVID Afflicts More Than 30% of Patients Following Infection with SARS-CoV-2, the Virus that Causes COVID-19, and is Expected to be a Global Health Burden

CHATHAM, N.J., April 06, 2022 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application to support a Phase 2 clinical trial with TNX-102 SL1 as a potential treatment for a subset of patients with Long COVID Syndrome (Long COVID) whose symptoms overlap with fibromyalgia. Long COVID is now known officially as Post-Acute Sequelae of COVID-19 (PASC2).

“We are excited to have received the FDA’s IND clearance to begin clinical trials of TNX-102 SL for the treatment of Long COVID,” said Seth Lederman, M.D., Chief Executive Officer of Tonix Pharmaceuticals. “Over 30% of people who recover from COVID-19 continue to experience a constellation of symptoms long past the time that they have recovered from acute COVID-19 illness3-4. The symptoms of Long COVID, which can include fatigue, multi-site pain, sleep disturbances, fevers, shortness of breath, cognitive impairment, gastrointestinal symptoms, anxiety, and depression, can persist for many months and can range from mild to incapacitating5. Our study will focus on testing TNX-102 SL in the treatment of patients with multi-site pain associated with Long COVID. This group of patients have symptoms that overlap with other chronic pain conditions, which as a group have been termed, ‘chronic overlapping pain conditions.’6,7 This type of pain syndrome is increasingly recognized as nociplastic pain,8 and the underlying mechanism as ‘central sensitization.’9 Fibromyalgia is considered one of the chronic overlapping pain conditions and our experience with TNX-102 SL in fibromyalgia is the motivation for undertaking the development of TNX-102 SL in patients with Long COVID whose symptoms overlap with fibromyalgia.”

About the Phase 2 Study

This Phase 2 study will be a double-blind randomized, placebo-controlled 14-week trial to evaluate the safety and efficacy of sublingual TNX-102 SL 5.6 mg daily at bedtime in the treatment of patients with multi-site pain associated with Long COVID. The trial will be conducted at approximately 30 sites to enroll approximately 470 patients (235 per arm) who will be randomized in a 1:1 ratio to treatment with TNX-102 SL or placebo tablets. The primary efficacy endpoint will be Change from Baseline in the weekly average of daily self-reported worst pain intensity scores at the Week 14 endpoint. An interim analysis is expected to be completed after the first 50% of enrolled patients have completed the study for the purpose of possible sample size re-estimation.

About Long COVID or Post-Acute Sequelae of SARS-CoV-2 (PASC)

Although most people recover from COVID-19 within weeks of the acute illness, a substantial portion develop a chronic syndrome called Long COVID. These individuals experience a constellation of disabling symptoms long past the time of recovery from acute COVID-19. Most Long COVID patients who have been studied appear to have cleared the SARS-CoV-2 infection from their systems. The symptoms of Long COVID can include fatigue, sleep disorders, multi-site pain, fevers, shortness of breath, cognitive impairment described as “brain fog” or memory disturbance, gastrointestinal symptoms, anxiety, and depression. Long COVID can persist for many months and can range in severity from mild to incapacitating. Several cohort studies have reported that persistence of symptoms following SARS-CoV-2 infection occurs in more than 30% of patients.3-5 While typically associated with moderate or severe COVID-19, Long COVID can occur after mild COVID-19 or even after asymptomatic SARS-CoV-2 infection. Patients with Long COVID are sometimes referred to as “long-haulers”. Long COVID is a chronic disabling condition that is expected to result in a significant global health and economic burden.10-13 In response to the urgent need for therapies that address Long COVID, Congress awarded $1.15 billion to the National Institutes of Health to study Long COVID in December 2020.14 While the vaccines available in the U.S. through either FDA approval or under Emergency Use Authorization have been shown to prevent acute COVID, their ability to prevent Long COVID is unknown. There is currently no approved drug for the treatment of Long COVID.

https://ca.finance.yahoo.com/news/tonix-pharmaceuticals-announces-ind-clearance-110000535.html

[Babubd]

Looking good indeed! NOT selling any shares till Dollars!! $TNXP

[tr5]

when ?

[Babubd]

Dollar Land!! $TNXP

[Babubd]

Gonna be an Insane Rise in SP!! TNXP will be @ Dollar Land!!

[TheFinalCD]

TODAYS NEWS https://finance.yahoo.com/news/tnxp-targeting-organ-transplant-rejection-103000220.html


TNXP

[Babubd]

DOLLARS INCOMING! PERIOD.

$TNXP

[Babubd]

Holding for Dollars! TNXP is the next OCGN!!

[Babubd]

Shorties game is over! We're gonna be back to Dollars any day now!! OCGN ran from $0.20 to $18+ within couple of days. I think TNXP is next!!

Tonix Pharmaceuticals Announces FDA Orphan-Drug Designation for TNX-2900 for the Treatment of Prader-Willi Syndrome
https://ca.finance.yahoo.com/news/tonix-pharmaceuticals-announces-fda-orphan-120000292.html

https://ca.finance.yahoo.com/news/tonix-pharmaceuticals-announces-fda-orphan-120000292.html

[Babubd]

Here comes the short squeeze! It's going to be awesome days!!

Let's go TNXP to Dollar Land!!

[Babubd]

TNXP to da MOOOOOON any day now!!

[Value_Investor]

I wish you were right, my friend! However I sold some shares at $0.265 ~ $0.2629 yesterday and my rest shares will be sold at $0.2651 ~ $0.36 if that is possible (unlikely). I'll use all the proceeds from liquidating TNXP to buy a OTC-CI tier hidden gem (which did quickly bounce to $0.0026 from $0.0005 just two months ago).

I'm sure TNXP will crash down to $0.15 or lower again due to the On-Going Endless Super Heavy dilutions...

[Babubd]

Holding for DOLLARS!! $TNXP

[Value_Investor]

TNXP declined to $0.22 today! So we should see it test $0.15 ~ $0.17 again in the coming days...

[Babubd]

TNXP holds CASH $178.66 million against $22.18 million total liabilities as at 2021-12-31!! WEEEEEEEEEEEEEEEE!! The company owns $240.90 million assets..Just beautiful! This will take off any day now.

[Babubd]

This is gonna be Dollars in the coming days. Let's go TNXP to $5++ !!

[UOENO]

weird that it is green today after the news this morning.

[Babubd]

She is headed to Dollar Land!! WEEEEEEEEEEEEEEEEEEE!!

Let's goooooooo TNXP to $5++!!

[Value_Investor]

No way, my friend! Again, the shorting position is nothing comparing to the Huge Endless-Super-Heavy-Diluting OS! I wish you were right so that I could get rid of rest shares at $0.2628 ~ $0.36! So far I only sold partial position at $0.25 ~ $0.2627 for very nice gain!

I bet $0.15 will be tested again in the coming days/weeks... TNXP closed at $0.24 today with a daily low $0.23!

[Babubd]

Gonna be an INSANE rise in SP! We're golden here! Dollars Coming in NO TIME!!

Let's go TNXP to $5++!!

[Babubd]

SHORTS ARE IN TROUBLE! THIS IS GONNA HIT DOLLARS IN THE COMING DAYS!!

LET'S GO TNXP TO $5++!!

[Value_Investor]

I started to sell my millions shares of TNXP at $0.25 and up to possible $0.36! I doubt if I could sell out all my shares since $0.36 will be a top-ceiling price? I bought my shares at as low as $0.15 anyway! Thanks for your buying my shares at $0.25xx today!

Again the shorted shares are only fractional of the entire On-Going-Super-Heavy-Diluting OS (534M shares as of 03/14/2022 alone)! Which means no shorting covering if TNXP can't break out $0.36! Hopefully TNXP will not break down the Bottom $0.15...

[Babubd]

Game Over Shorts! 5+ Dollars!! Mark my words.

$$$TNXP$$$$$$$$$$

[Babubd]

Dollars Baby Dollars!! Mark my words.

Let's go TNXP to $5++!!

[Babubd]

Dollars incoming! TNXP is the next OCGN!! Mark my words.

Let's go TNXP to Dollar Land!!